nitroglycerin has been researched along with atorvastatin in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 9 (56.25) | 29.6817 |
| 2010's | 7 (43.75) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Böhm, M; Hilgers, S; Laufs, U; Nickenig, G; Ribaudo, N; Wassmann, S | 1 |
| Duffy, SJ; Gokce, N; Holbrook, M; Kahn, D; Keaney, JF; Palmisano, J; Thomas, S; Tomasian, D; Vita, JA | 1 |
| Berkenboom, G; Fontaine, D; Fontaine, J; Otto, A | 1 |
| Böhm, M; Faul, A; Laufs, U; Nickenig, G; Ribaudo, N; Wassmann, S | 1 |
| Caselli, A; Economides, PA; Horton, ES; Khaodhiar, L; Tiani, E; Veves, A | 1 |
| Chan, DC; Dogra, GK; Stanton, K; Watts, GF | 1 |
| Candura, D; Chello, M; Covino, E; Di Sciascio, G; Goffredo, C; Mastrobuoni, S; Melfi, R; Patti, G | 1 |
| Frøbert, O; Holmager, P; Jensen, KM; Schmidt, EB; Simonsen, U | 1 |
| Fang, Y; Li, X; Lin, J; Ren, L; Wang, X; Yin, Z; Zhang, A | 1 |
| Aydin, C; Baysal, A; Bugra, O; Buyukbayrak, F; Caliskan, A; Erdem, H; Fedekar, A; Sasmazel, A; Sunar, H | 1 |
| Di Stolfo, G; Gori, T; Liuni, A; Luca, MC; Mariani, JA; Parker, JD; Uxa, A | 1 |
| Chedgy, F; Howlett, DC; Inglis, C | 1 |
| Han, SH; Jang, Y; Koh, KK; Oh, PC; Park, YM | 1 |
| Cui, L; Li, F; Wang, J; Yang, F | 1 |
1 review(s) available for nitroglycerin and atorvastatin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
8 trial(s) available for nitroglycerin and atorvastatin
| Article | Year |
|---|---|
Effect of atorvastatin on endothelium-dependent vasodilation in patients with coronary artery disease.
Topics: Aged; Atorvastatin; Blood Flow Velocity; Blood Pressure; Cholesterol, HDL; Cholesterol, LDL; Coronary Artery Disease; Double-Blind Method; Endothelium, Vascular; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Male; Middle Aged; Muscle, Smooth, Vascular; Nitroglycerin; Pyrroles; Syndrome; Time Factors; Treatment Outcome; Vasodilation; Vasodilator Agents | 2003 |
Effect of atorvastatin 80 mg on endothelial cell function (forearm blood flow) in patients with pretreatment serum low-density lipoprotein cholesterol levels <130 mg/dl.
Topics: Administration, Oral; Anticholesteremic Agents; Atorvastatin; Blood Flow Velocity; Brachial Artery; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Double-Blind Method; Drug Administration Schedule; Endothelium, Vascular; Female; Forearm; Heptanoic Acids; Humans; Hypercholesterolemia; Hyperemia; Male; Middle Aged; Nitroglycerin; Pulsatile Flow; Pyrroles; Treatment Outcome; Triglycerides; Vasodilation | 2004 |
The effects of atorvastatin on endothelial function in diabetic patients and subjects at risk for type 2 diabetes.
Topics: Adult; Atorvastatin; Biomarkers; Brachial Artery; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Double-Blind Method; Endothelium, Vascular; Female; Forearm; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Male; Microcirculation; Middle Aged; Nitroglycerin; Pyrroles; Regional Blood Flow; Risk Factors; Skin; Vasodilation; Vasodilator Agents | 2004 |
Statin therapy improves brachial artery vasodilator function in patients with Type 1 diabetes and microalbuminuria.
Topics: Adolescent; Adult; Aged; Albuminuria; Apolipoproteins B; Atorvastatin; Brachial Artery; Cholesterol, LDL; Cross-Over Studies; Cyclic GMP; Diabetes Mellitus, Type 1; Double-Blind Method; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Linear Models; Lipoproteins, LDL; Male; Middle Aged; Nitroglycerin; Pyrroles; Regional Blood Flow; Statistics, Nonparametric; Vasodilation; Vasodilator Agents | 2005 |
Effects of atorvastatin on arterial endothelial function in coronary bypass surgery.
Topics: Adult; Aged; Analysis of Variance; Atorvastatin; Brachial Artery; Cholesterol; Coronary Artery Bypass; Double-Blind Method; Endothelium, Vascular; Female; Hemodynamics; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperemia; Male; Middle Aged; Nitroglycerin; Postoperative Period; Pyrroles; Statistics, Nonparametric; Vasodilation; Vasodilator Agents | 2005 |
Effect of acute changes in oxygen tension on flow-mediated dilation. Relation to cardivascular risk.
Topics: Administration, Inhalation; Adult; Atorvastatin; Brachial Artery; Cardiovascular Diseases; Cholesterol; Endothelium, Vascular; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Hyperoxia; Hypoxia; Lipoproteins; Male; Middle Aged; Nitroglycerin; Oxygen; Pyrroles; Regional Blood Flow; Research Design; Risk Factors; Treatment Outcome; Triglycerides; Ultrasonography; Vasoconstriction; Vasodilation; Vasodilator Agents | 2008 |
The effect of statin therapy on stimulation of endothelium-derived nitric oxide before and after coronary artery bypass surgery.
Topics: Aged; Atorvastatin; Cardiopulmonary Bypass; Coronary Artery Bypass; Coronary Artery Disease; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperemia; Intraoperative Period; Male; Middle Aged; Nitric Oxide; Nitroglycerin; Postoperative Care; Preoperative Care; Pyrroles; Vasodilator Agents | 2010 |
Coadministration of atorvastatin prevents nitroglycerin-induced endothelial dysfunction and nitrate tolerance in healthy humans.
Topics: Adolescent; Adult; Atorvastatin; Blood Pressure; Brachial Artery; Double-Blind Method; Drug Administration Routes; Drug Tolerance; Endothelium, Vascular; Heart Rate; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Nitroglycerin; Oxidative Stress; Pyrroles; Reference Values; Vasodilation; Vasodilator Agents; Young Adult | 2011 |
7 other study(ies) available for nitroglycerin and atorvastatin
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Rapid effects on vascular function after initiation and withdrawal of atorvastatin in healthy, normocholesterolemic men.
Topics: Adult; Atorvastatin; Blood Flow Velocity; C-Reactive Protein; Cholesterol; Endothelium, Vascular; Forearm; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Nitroglycerin; Plethysmography; Pyrroles; Reference Values; Vasodilation | 2001 |
Prevention of nitrate tolerance by long-term treatment with statins.
Topics: Administration, Oral; Animals; Aorta, Thoracic; Atorvastatin; Down-Regulation; Drug Administration Schedule; Drug Tolerance; Guanylate Cyclase; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Injections, Subcutaneous; Luminescent Measurements; Male; NADH, NADPH Oxidoreductases; NADPH Oxidases; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Nitroglycerin; Pravastatin; Pyrroles; Rats; Rats, Wistar; Superoxides; Vasodilator Agents | 2003 |
Atorvastatin attenuates NF-kappaB activation in trigeminal nucleus caudalis in a rat model of migraine.
Topics: Analysis of Variance; Animals; Atorvastatin; Blotting, Western; Cell Nucleus; Disease Models, Animal; Dose-Response Relationship, Drug; Fluorescent Antibody Technique; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Migraine Disorders; Neoplasm Proteins; Neurons; NF-kappa B; Nitroglycerin; Nucleocytoplasmic Transport Proteins; Pyrroles; Rats; Rats, Sprague-Dawley; Trigeminal Caudal Nucleus | 2009 |
A case of recurrent ventricular tachycardia.
Topics: Aged; Atorvastatin; Cardiovascular Agents; Digoxin; Drug Therapy, Combination; Female; Furosemide; Heptanoic Acids; Humans; Isosorbide Dinitrate; Lisinopril; Nitroglycerin; Pyrroles; Recurrence; Tachycardia, Ventricular; Warfarin | 2011 |
Diffuse three-vessel coronary artery spasm.
Topics: Atorvastatin; Coronary Vasospasm; Diagnosis, Differential; Diagnostic Imaging; Diltiazem; Drug Therapy, Combination; Electrocardiography; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Isosorbide Dinitrate; Male; Middle Aged; Nitroglycerin; Pyrroles; Risk Factors; Vasodilator Agents | 2015 |
Atorvastatin Combined Nitroglycerin Therapy Confer Additive Effects on Rabbits with Dyslipidemia.
Topics: Animals; Atorvastatin; Disease Models, Animal; Drug Therapy, Combination; Dyslipidemias; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Nitric Oxide; Nitroglycerin; Rabbits; rho-Associated Kinases; Vasodilator Agents | 2016 |